|
Volumn 38, Issue 4, 2014, Pages E309-E319
|
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ADOLESCENT;
ADULT;
AGED;
AUSTRALIA;
BACTEREMIA;
CELL CLONE;
CHILD;
CLASSIFICATION;
CROSS INFECTION;
DRUG EFFECTS;
EPIDEMIOLOGICAL MONITORING;
FEMALE;
GENETICS;
GROWTH, DEVELOPMENT AND AGING;
HEALTH CARE MANAGEMENT;
HUMAN;
INFANT;
MALE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TEST;
MICROBIOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIDRUG RESISTANCE;
NEWBORN;
PRESCHOOL CHILD;
SEPSIS;
SEROTYPING;
STAPHYLOCOCCAL INFECTIONS;
SURVIVAL;
TREATMENT OUTCOME;
VERY ELDERLY;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANNUAL REPORTS AS TOPIC;
ANTI-BACTERIAL AGENTS;
AUSTRALIA;
BACTEREMIA;
CHILD;
CHILD, PRESCHOOL;
CLONE CELLS;
CROSS INFECTION;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
EPIDEMIOLOGICAL MONITORING;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
SEPSIS;
SEROTYPING;
STAPHYLOCOCCAL INFECTIONS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 84942574375
PISSN: 14474514
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|